HSF1 and malignant colon neoplasm: We found that knockdown of HSF1 sensitizes cancer cells to HSP90 inhibitors in many different cancer lineages, including melanoma (A375, A2058), hepatocellular carcinoma (Hep3B, Huh7) and colon cancer (HCT116).